This inventor holds 1 USPTO granted patent. Top assignee: Lg Life Sciences, Limited. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Hyun-lk Shin: Innovator in Beta-Ketoester Compound Synthesis
Introduction
Hyun-lk Shin is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of chemistry, particularly in the synthesis of beta-ketoester compounds. His work has implications for the development of important antibiotics.
Latest Patents
Hyun-lk Shin holds a patent for a process for preparing beta-ketoester compounds. This invention relates to a new method for synthesizing beta-ketoester compounds, which serve as useful intermediates in the production of quinoline antibiotics such as Ciprofloxacin, Levofloxacin, Gemifloxacin, and Trovafloxacin. The quinoline antibiotics derived from this compound exhibit potent antibacterial activity, making them valuable therapeutic agents for treating bacterial infections in both humans and animals.
Career Highlights
Hyun-lk Shin is associated with LG Life Sciences, Limited, where he applies his expertise in chemical synthesis. His innovative approach has led to advancements in antibiotic development, showcasing his commitment to improving healthcare through scientific research.
Collaborations
He has collaborated with notable colleagues, including Sang-Chul Choi and Bo-Seung Choi, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Hyun-lk Shin's work in the synthesis of beta-ketoester compounds highlights his role as a key inventor in the field of chemistry. His contributions not only advance scientific knowledge but also have practical applications in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile